$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
2021年靶向药维莫非尼医保报销比例
2025-10-19 11:44:20
Check Details
术后黑色素瘤可以使用维莫非尼吗?
2025-10-19 11:44:20
Check Details
【用药早知道】维莫非尼是治疗什么病症的药?
2025-10-19 11:44:20
Check Details
靶向药佐博伏(维莫非尼)需要长期服用吗?
2025-10-19 11:44:20
Check Details
2021年佐博伏(维莫非尼)医保报销后的价格
2025-10-19 11:44:20
Check Details
佐博伏(维莫非尼)可以报销吗?报销条件是什么?
2025-10-19 11:44:20
Check Details
达拉非尼联合曲美替尼用于黑色素瘤的优势有什么?
2025-10-19 11:44:20
Check Details
国内达拉非尼和曲美替尼在哪可以买到?
2025-10-19 11:44:20
Check Details
达拉非尼和曲美替尼联用疗效好吗?
2025-10-19 11:44:20
Check Details
甲磺酸达拉非尼胶囊多少钱一瓶?2021年入医保了吗?
2025-10-19 11:44:20
Check Details
已上市的抗癌药曲美替尼价格,2021年多少钱
2025-10-19 11:44:20
Check Details
达拉非尼联合曲美替尼治疗晚期黑色素瘤,可以治好吗?
2025-10-19 11:44:20
Check Details
1
2
...
6749
6750
6751
6752
6753
6754
6755
...
10242
10243
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Sparsentan Drug Interactions: Hypotension, Hyperkalemia, Renal Risk, CYP3A
2
How to Take Vigabatrin: Dosing and Vision Monitoring
3
Who Makes Belzutifan: Welireg and Merck/ MSD Explained
4
FDA Approves Infilbray for GD3 Neurological Symptoms
5
How to Take Selinexor: Dosing, Food, and Safety
6
FDA Approves Nelkarmi for ALK-TKI-Resistant NSCLC
7
FDA Approves Lembaz: First Therapy Shown to Extend Survival in Infantile-Onset NPC
8
Klygefa FDA Approval: Weekly Subcutaneous C5 Inhibition for AChR-Positive gMG
9
What Is Pralsetinib? RET-Positive Lung and Thyroid Cancer Explained
10
Sotorasib Diarrhea in NSCLC: Grading, Loperamide and Dose Adjustment
11
Avatrombopag vs Eltrombopag in ITP: Onset, Dosing Rules and Pre‑Procedure Use
12
Gilteritinib and Differentiation Syndrome in AML: Recognition, Emergency Management and Monitoring